Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-14 of 14 for your search:
Cancer Type/Condition:
Colon cancer
Trial Type:
Prevention
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Selenium in Treating Patients With Adenomatous Colorectal Polyps
Phase:
Phase III
Type:
Prevention
Status:
Active
Age:
40 to 80
Sponsor:
NCI
Protocol IDs:
UARIZ-00-0430-01
, 00-0430-01, UARIZ-HSC-00142, NCT00078897
2.
Effect of Vitamin E and/or Selenium on Colorectal Polyps in Men Enrolled on SELECT Trial SWOG-S0000
Phase:
Phase III
Type:
Natural history/Epidemiology, Prevention
Status:
Active
Age:
50 and over
Sponsor:
NCI
Protocol IDs:
SWOG-S0000D
, S0000D, NCT00706121
3.
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Phase:
Phase III
Type:
Biomarker/Laboratory analysis, Prevention, Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NSABP-P-5
, NSABP P-5, NCT01011478
4.
Curcumin for the Chemoprevention of Colorectal Cancer
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
Over 18
Sponsor:
Other
Protocol IDs:
802193
, NCT00118989
5.
Influence of Sulindac and Probiotics on the Development of Pouch Adenomas in Patients With Familial Adenomatous Polyposis
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
16 and over
Sponsor:
Other
Protocol IDs:
23266
, KUN 2003-2911, NCT00319007
6.
Polyethylene Glycol 3350 in Preventing Cancer in Patients at Risk of Colorectal Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NU-NWU06-8-01
, NWU06-8-01, NWU-06-8-01, NCI-06-8-01, NCT00828984
7.
Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma
Phase:
Phase II
Type:
Prevention
Status:
Active
Age:
40 to 70
Sponsor:
NCI, Other
Protocol IDs:
PRO07030214
, NIH grant 5P01 CA73743-08, NCT00773097
8.
Aspirin and Eflornithine in Treating Patients at High Risk for Colorectal Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Natural history/Epidemiology, Prevention
Status:
Active
Age:
40 to 120
Sponsor:
Other
Protocol IDs:
NCI-2009-01192
, MC054A, NCT00983580
9.
Vitamin D for Chemoprevention
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
30 to 80
Sponsor:
Other
Protocol IDs:
07-342
, NCT00585637
10.
Vitamin D Supplement in Preventing Colon Cancer in African Americans With Colon Polyps
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
50 and over
Sponsor:
NCI
Protocol IDs:
NU-08I3
, NU 08I3, NCT00870961
11.
Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
LRI-UL-CURCUMIN
, UL-CURCUMIN, EUDRACT-2007-001971-13, EU-20961, NCT00973869
12.
Celecoxib in Treating Patients With Familial Adenomatous Polyposis
Phase:
No phase specified
Type:
Prevention
Status:
Active
Age:
16 and over
Sponsor:
NCI
Protocol IDs:
MDA-DM-02592
, NCT00258219
13.
Healthy Eating for Colon Cancer Prevention
Phase:
No phase specified
Type:
Prevention, Treatment
Status:
Active
Age:
21 and over
Sponsor:
Other
Protocol IDs:
HUM00007622
, NCT00475722
14.
High Legume Diet in Preventing Cancer in Patients at High Risk for Recurrent Colorectal Cancer
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Prevention
Status:
Active
Age:
Adult
Sponsor:
NCI
Protocol IDs:
NCI-05-C-N215
, 05-C-N215, NCT00339469
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
